Related Experiment Video
Updated: Sep 26, 2025
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
22.1K
Gestational Thrombocytopenia: A Review on Recent Updates
Elmukhtar Habas1,2, Amnna Rayani3, Gamal Alfitori2
1Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Cureus
|April 21, 2022
Summary
Gestational thrombocytopenia (GT), a common condition in pregnancy with low platelet counts, is likely a physiological response. Current understanding lacks specific causes and treatments, necessitating further research into its pathophysiology.
Area of Science:
- Obstetrics and Gynecology
- Hematology
Background:
- Thrombocytopenia, characterized by low blood platelet counts, is frequently observed in pregnancy.
- Mild thrombocytopenia during pregnancy, now known as gestational thrombocytopenia (GT), is common.
- GT incidence increases with a history of the condition and in multiple pregnancies.
Purpose of the Study:
- To review recent updates on the pathophysiology and treatment of gestational thrombocytopenia (GT).
- To explore the physiological basis of GT, considering placental structure and blood flow.
- To identify gaps in knowledge regarding GT mechanisms and management strategies.
Main Methods:
- A non-systematic review of recent literature.
- Searches conducted in PubMed, EMBASE, and Web of Science databases.
- Focus on studies concerning GT pathophysiology, treatment, and related topics.
Main Results:
- Gestational thrombocytopenia (GT) is considered a physiological response to pregnancy.
- Placental structure and unique blood flow patterns are implicated in GT development.
- Specific pathophysiological mechanisms and novel management strategies for GT remain largely unknown.
Conclusions:
- Gestational thrombocytopenia (GT) is a prevalent condition in pregnancy with unclear underlying mechanisms.
- Existing research highlights the physiological nature of GT, influenced by placental factors.
- Further investigation is required to elucidate GT pathophysiology and develop targeted treatments.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
37
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
37
01:30Venous Thrombosis I: Introduction
49
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
49
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
59
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
59
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
662
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
662
01:30Venous Thrombosis IV: Nursing Management
37
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
37
01:16Clot Retraction and Fibrinolysis
7.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.0K